Cancer
Arius Announces First Quarter Fiscal 2007 Financial Results
Published in Medical Patent Business Week, May 4th, 2007
"Our primary focus for 2007 will be to advance ARIUS-originated antibodies towards clinical development," said Dr. David Young, President and CEO. "During the quarter, we focused on moving our three lead antibody programs into pre-IND enabling studies in preparation for toxicology studies later in 2007 and human clinical trials planned for 2008. We also continued to support our numerous research partnerships, delivering...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
More Articles from Medical Patent Business Week
- Autoimmune Disease
Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology - B-Cell Lymphoma
Data Presented at AACR Meeting Shows Peregrine's Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies - Biomedical Engineering
Researchers develop technique for bacteria crowd control - Biotech Business
Miller Canfield Opens Office in Cambridge, Mass.; Expands Biotechnology, IP and Life Sciences Practice - Biotechnology
Congressman Van Hollen Honored as BIO Legislator of the Year - Biotechnology
Senator Baucus Honored as BIO Legislator of the Year - More from this issue of Medical Patent Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
